Focused On Life
Developing novel therapies for serious diseases
Driven By Science
Rapid, efficient, cost-effective approach
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families.
Latest News
Astellas and Medivation Announce Submission of Application for Marketing Approval of Enzalutamide, an Oral Androgen Receptor Inhibitor, in Japan Learn More